Zheng Zhi, Yin Jie, Liu Xiao-Ye, Yan Xiao-Sheng, Xu Rui, Li Meng-Yi, Cai Jun, Chen Guang-Yong, Zhang Jun, Zhang Zhong-Tao
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
World J Gastrointest Oncol. 2021 Jun 15;13(6):560-573. doi: 10.4251/wjgo.v13.i6.560.
The development of endoscopic treatment technology has further promoted the minimally invasive treatment of early gastric cancer (EGC). Endoscopic treatment has achieved better therapeutic effects in terms of safety and prognosis and is the preferred treatment method for patients who meet the indications for endoscopic treatment. However, the consequent problem is that some patients receiving endoscopic treatment may undergo non-curative resection, and the principle of follow-up management for non-curative resection patients deserves further attention. In addition, there are still debates on how to improve the accuracy of clinical staging, select a reasonable treatment method for patients who meet the expanded indications for endoscopic treatment, manage patients with positive endoscopic surgical margins, conduct research on function-preserving surgery, and manage the treatment of EGC under the current situation in China. Consequently, we aim to review current indications for endoscopic submucosal dissection of EGC in order to better inform treatment options.
内镜治疗技术的发展进一步推动了早期胃癌（EGC）的微创治疗。内镜治疗在安全性和预后方面取得了较好的治疗效果，是符合内镜治疗适应证患者的首选治疗方法。然而，随之而来的问题是，一些接受内镜治疗的患者可能会进行非根治性切除，非根治性切除患者的随访管理原则值得进一步关注。此外，关于如何提高临床分期的准确性、为符合内镜治疗扩大适应证的患者选择合理的治疗方法、处理内镜手术切缘阳性的患者、开展保留功能手术的研究以及在中国当前形势下管理EGC的治疗等问题仍存在争议。因此，我们旨在回顾目前EGC内镜黏膜下剥离术的适应证，以便更好地指导治疗选择。
